Johnson & Johnson’s (NYSE:JNJ) DePuy Synthes said it has launched its Symphony occipito-cervico-thoracic system to expand its portfolio of surgical treatments for the neck and upper back.
The Symphony system is designed to stabilize the spine in patients undergoing posterior cervical fusion surgery. It is meant to help streamline procedures and create efficiencies for the surgeon and operating room staff in fixation, alignment, targeting and extensions, according to DePuy Synthes. The system is compatible with navigation software to help targeting in challenging anatomy, the company added.
Meant for patients with suboptimal bone quality, Symphony is designed to improve fixation and address a potential cause of screw failure that may lead to revision surgery. Symphony crosses the cervical to the thoracic junction, reducing the number of instrument trays from six to two, the company said.
It is also one of the first posterior cervical systems that is offered with sterile packed implants, which may reduce costs as well.
“The Symphony system builds on the deep expertise of DePuy Synthes in treating diseases that affect the cervical spine, and we are excited to elevate our existing portfolio by offering this new enhanced solution for the treatment of these debilitating conditions,” DePuy Synthes worldwide president, spine, Nadav Tomer said in the release. “This launch represents an incredible global opportunity to bring a differentiated solution to surgeons looking for reduced complexity, streamlined procedures and more flexibility in treatment options for their patients.”
“The most interesting aspect of the Symphony system is its ability to address highly complex needs that we face at the front lines of cervical spine surgery,” added University of California, San Francisco neurospinal disorders program co-director Dr. Christopher Ames. “It also takes into account ways to create efficiencies for healthcare systems, making it a truly comprehensive offering.”
